Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an undisclosed sum so as to power a broad pipeline when it comes to antibody conjugates for approval of drugs. Apparently, this filing goes on to extend the recent large number of […]
Siemens Healthineers To Grow PET Imaging Via Novartis Assets
In a recent development taking place in the last week of August 2024, Siemens Healthineers has gone ahead and agreed to pay over 200 million euros, which is equivalent to $223 million, to purchase a part of the radiopharmaceutical business of Novartis. The report has been brought to the fore by the Financial Times. The […]
The cell and gene therapy revolution: Milestones, mindsets and the path forward
The evolving landscape of cell and gene therapies (C>s) holds transformative potential for the future of medicine. From early experimental trials to groundbreaking FDA approvals, the journey of C>s has been marked by rapid advancements and significant hurdles. In this article, Bill Vincent, an experienced C> Biotech Founder and CEO, delves into the key milestones […]
Ensuring Pharmaceutical Safety With Cold Chain Strategy
Supply chain optimization for the safety of pharmaceuticals As summertime temperatures increase, it becomes more crucial to ensure the safety of pharmaceutical items. Elevated temperatures have the potential to greatly impact the quality of products, which might have detrimental effects on patient safety and adherence to regulations. As such, one of the most important components […]
Global Pharma Packaging Market Set For Decade-Long Growth
Over the course of the next ten years, the global market for pharmaceutical grade plastic packaging is expected to see consistent growth. Over the next ten years, the global market for pharmaceutical grade plastic packaging is likely to see tremendous expansion. It is anticipated that sales will reach USD 56.6 billion in 2024 and then […]
Fujitsu tackles drug loss in Japan through ecosystem to accelerate digitalization of clinical trials
Fujitsu announced that it will begin initiatives to attract global clinical trials to Japan and tackle the ‘drug loss’ issue by working with pharmaceutical companies and medical institutions to build a new medical data ecosystem. The efforts come under the Fujitsu Uvance Healthy Living, which aims to improve people’s well-being. In July 2024, Fujitsu formed […]
EC approves Celltrion’s SteQeyma, a biosimilar to Stelara for the treatment of multiple chronic inflammatory diseases
The European Commission (EC) approval is based on the totality of evidence including the results from a Phase III study in adults with moderate to severe plaque psoriasis. Celltrion today announced that the European Commission (EC) has approved the use of SteQeyma® (CT-P43), an ustekinumab biosimilar referencing Stelara®, for the treatment of multiple chronic inflammatory […]
Bisam Pharmaceuticals Unveils Quick Vitals: The World’s First AI and Deep Learning-Powered Health Monitoring App
Bisam Pharmaceuticals has launched “Quick Vitals,” the world’s first health monitoring application powered by AI and Deep Learning technologies. The launch event took place at Hotel Avasa in Hyderabad, marking a significant milestone in the intersection of technology and healthcare. Transforming Health Monitoring with AI “Quick Vitals” offers a revolutionary approach to health monitoring through […]
Nuclear Medicine In North America: Market Growth & Trends
The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to develop rapidly over the next few years, with a compound annual growth rate (CAGR) of 9.90% through 2029. Within the healthcare sector, the nuclear medicine market is a vibrant and quickly developing area. It includes […]
Bayer & NextRNA Partner In $547Million Cancer Therapy Deal
This summer, Bayer officials made sure Fierce understood that the company’s desire for deals hasn’t been stifled by a group-wide reorganization. Its most recent partnership aimed at treating cancer indicates that Bayer has, in fact, not lost interest in novel and exciting approaches. An agreement for over half a billion biobucks was inked by the […]
